Vol. 14. Núm. 29.
Páginas 1769-1774 (Marzo 2025)

Protocolos de práctica asistencial
Protocolo diagnóstico y terapéutico de la anafilaxia

Diagnostic and treatment protocol for anaphylaxis

I. Roibás VeigaaP. Méndez BreaaT. González VidalaC. Vidal Panb
Doi : https://10.1016/j.med.2025.04.007
Opciones
Resumen

La anafilaxia es la reacción alérgica de mayor gravedad. Un diagnóstico precoz y la administración urgente del tratamiento de elección son cruciales para salvar la vida de los pacientes afectos. El código anafilaxia puesto en marcha por el Servicio Galego de Saúde constituye la mejor aproximación al diagnóstico y tratamiento de esta entidad, y asegura una vía rápida de atención al paciente con una reacción anafiláctica.

Palabras clave
Inmunoglobulina E
Triptasa
Adrenalina
Anafilaxia
Riesgo fatal
Fármacos
Alimentos
Venenos de los himenópteros
Abstract

Anaphylaxis is the most severe allergic reaction. Early diagnosis and urgent administration of the treatment of choice are crucial in order to save the lives of affected patients. The anaphylaxis code implemented by the Galician Health Service is the best approach to the diagnosis and treatment of this disease. It ensures a rapid care pathway for patients with an anaphylactic reaction.

Keywords
Immunoglobulin E
Tryptase
Adrenaline
Anaphylaxis
Fatal risk
Drugs
Food
Hymenoptera venoms

Identifíquese

¿Aún no es suscriptor de la revista?

Comprar el acceso al artículo

Comprando el artículo el pdf del mismo podrá ser descargado

Teléfono para incidencias

De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h

Llamadas desde España 932 415 960
Llamadas desde fuera de España +34 932 415 960
Bibliografía
[1]
M. Tejedor-Alonso
202504141240008688
, M. Moro-Moro, M.V. Múgica-García.
Epidemiology of Anaphylaxis: Contributions from the Last 10 Years.
J Investig Allergol Clin Immunol., (2015), 25 pp. 163-175
[2]
Y. Wang
202504141240008689
, K.J. Allen, N.H.A. Suaini, V. McWilliam, R.L. Peters, J.J. Koplin.
The global incidence and prevalence of anaphylaxis in children in the general population: A systematic review.
Allergy., (2019), 74 pp. 1063-1080
[3]
M.M. Peng
2025041412400086810
, H. Jick.
A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom.
Arch Intern Med., (2004), 164 pp. 317-319
[4]
M. Currie
2025041412400086811
, R.K. Kerridge, A.K. Bacon, J.A. Williamson.
Crisis management during anaesthesia: anaphylaxis and allergy.
Qual Saf Health Care., (2005), 14 pp. e19
[5]
M.A.T. Alonso
2025041412400086812
, M.V.M. García, J.E. Hernández, M.M. Moro, P.E.R.P. Ezquerra, A.R. Ingelmo, et al.
Recurrence of anaphylaxis in a Spanish series.
J Investig Allergol Clin Immunol., (2013), 23 pp. 383-391
[6]
S. Lee
2025041412400086813
, M.F. Bellolio, E.P. Hess, P. Erwin, M.H. Murad, R.L. Campbell.
Time of onset and predictors of biphasic anaphylactic reactions: A systematic review and meta-analysis.
J Allergy Clin Immunol Pract., (2015), 3
[7]
European
2025041412400086814
2025041412400086815
Academy of Allergy, Clinical Immunology FA, Anaphylaxis Guidelines Group, A. Muraro, M. Worm, C. Alviani, V. Cardona, A. DunnGalvin, et al.
EAACI guidelines: Anaphylaxis (2021 update).
Allergy., (2022), 77 pp. 357-377
[8]
S.S. Panesar
2025041412400086816
, S. Javad, D. de Silva, B.I. Nwaru, L. Hickstein, A. Muraro, et al.
The epidemiology of anaphylaxis in Europe: a systematic review.
Allergy., (2013), 68 pp. 1353-1361
[9]
J. Rivera
2025041412400086817
, A.M. Gilfillan.
Molecular regulation of mast cell activation.
J Allergy Clin Immunol, (2006), 117 pp. 1214-1225
[10]
B. De la Hoz Caballer
2025041412400086818
2025041412400086819
, M.D.C. Diéguez Pastor, D. González de Olano, A. Habernau Mena, R. Muñoz Cano.
Guía de actuación en anafilaxia: GALAXIA.
(2022),
[11]
P. Ribó
2025041412400086820
, Y. Guo, J. Aranda, E. Ainsua-Enrich, A. Navinés-Ferrer, M. Guerrero, et al.
Mutation in KARS: A novel mechanism for severe anaphylaxis.
J Allergy Clin Immunol., (2021), 147
[12]
P. Vadas
2025041412400086821
, B. Perelman, G. Liss.
Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis.
J Allergy Clin Immunol., (2013), 131 pp. 144-149
[13]
R.M. Muñoz-Cano
2025041412400086822
, R. Casas, G. Araujo, C. de la Cruz, M. Martin, J. Roca-Ferrer, et al.
Prostaglandin E2 decreases basophil activation in patients with food-induced anaphylaxis.
Allergy., (2021), 76 pp. 1556-1559
[14]
V. Cardona
2025041412400086823
2025041412400086824
, I.J. Ansotegui, M. Ebisawa, Y. El-Gamal, M. Fernandez Rivas, S. Fineman, et al.
World allergy organization anaphylaxis guidance 2020.
World Allergy Organ. J, (2020), 13 pp. 100472
[15]
C. Lott
2025041412400086825
, A. Truhlář, A. Alfonzo, A. Barelli, V. González-Salvado, J. Hinkelbein, et al.
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances.
Resuscitation., (2021), 161 pp. 152-219
[16]
J. Anchor
2025041412400086826
, R.A. Settipane.
Appropriate use of epinephrine in anaphylaxis.
Am J Emerg Med., (2004), 22 pp. 488-490
[17]
N. Patel
2025041412400086827
, K.W. Chong, A.Y.G. Yip, D. Ierodiakonou, J. Bartra, R.J. Boyle, et al.
Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis.
J Allergy Clin Immunol., (2021), 148 pp. 1307-1315
[18]
G. Marone
2025041412400086828
, M. Bova, A. Detoraki, A.M. Onorati, F.W. Rossi, G. Spadaro.
The human heart as a shock organ in anaphylaxis.
Novartis Found Symp., (2004), 257 pp. 133-149
[19]
J. Ring
2025041412400086829
, K. Beyer, T. Biedermann, A. Bircher, M. Fischer, T. Fuchs, et al.
Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update.
Allergo J Int., (2021), 30 pp. 1-25
[20]
F.E.R. Simons
2025041412400086830
2025041412400086831
, L.R.F. Ardusso, M.B. Bilò, Y.M. El-Gamal, D.K. Ledford, J. Ring, et al.
World Allergy Organization Guidelines for the assessment and management of anaphylaxis.
World Allergy Organ J., (2011), 4 pp. 13-37
[21]
A.F.T. Brown
2025041412400086832
.
Anaphylaxis gets the adrenaline going.
Emerg Med J., (2004), 21 pp. 128-129
[22]
W. Alqurashi
2025041412400086833
, A.K. Ellis.
Do corticosteroids prevent biphasic anaphylaxis?.
J Allergy Clin Immunol Pract., (2017), 5 pp. 1194-1205
[23]
Joint
2025041412400086834
Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology.
The diagnosis and management of anaphylaxis: an updated practice parameter.
J Allergy Clin Immunol., (2005), 115 pp. S483-S523
[24]
P. Valent
2025041412400086835
, P. Bonadonna, K. Hartmann, S. Broesby-Olsen, K. Brockow, J.H. Butterfield, et al.
Why the 20%+2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome.
Int Arch Allergy Immunol., (2019), 180 pp. 44-51
[25]
P. Sellaturay
2025041412400086836
, S. Nasser, P. Ewan.
Polyethylene glycol-induced systemic allergic reactions (anaphylaxis).
J Allergy Clin Immunol Pract., (2021), 9 pp. 670-675